The Board of Directors of the Atlanpole Biotherapies cluster elected on September 21, 2021 for 3 years

Board of Atlanpole Biotherapies

  • President : Franck GRIMAUD – Valneva
  • Executive vice-president : Jean-François BALDUCCHI –  Atlanpole
  • Vice-president Immunotherapies : Maryvonne HIANCE – OSE Immunotherapeutics
  • Vice-president Regenerative medicine  : Franck ZAL – Hemarina
  • Vice-president Radiopharmaceuticals : Ferid HADDAD – GIP Arronax
  • Vice-president Clinical : Benoit Labarthe – CHU de Nantes
  • Vice-president External relations : Olivier BOISTEAU – Clean Biologics
  • Vice-president Academic : Charles PINEAU – Université de Rennes 1
  • Treasurer : Serge RICHARD – ERBC Baugy Facility
  • Secretary : Louis-Marie BACHELOT – GlioCure

Private College

  • Louis-Marie Bachelot – GLIOCURE
  • Olivier Boisteau – CLEAN BIOLOGICS
  • Pascal Breton – WAVEIMPLANT
  • Benoit Fouchaq – BIOFORTIS
  • Philippe Gaudin – THERMO FISHER SCIENTIFIC
  • Franck Grimaud – VALNEVA
  • Maryvonne Hiance – OSE IMMUNOTHERAPEUTICS
  • Ronan Le Bot – ATLANTA
  • Cyrille Loncle – IDBC
  • Serge Richard – ERBC BAUGY FACILITY
  • Marwan Touati – PAREAN BIOTECHNOLOGIES
  • Franck Zal – HEMARINA

Higher education schools, research and care College

  • Loïc Carballido – CHU D’ANGERS
  • Patrick Emond – UNIVERSITÉ DE TOURS
  • Férid Haddad – GIP ARRONAX
  • Frédéric Jacquemin – UNIVERSITÉ DE NANTES
  • Benoît Labarthe – CHU DE NANTES
  • Sidonie Lavergne – INSTITUT DE CANCÉROLOGIE DE L’OUEST
  • Charles Pineau – UNIVERSITÉ DE RENNES 1
  • Pascal Richomme-Peniguel – UNIVERSITÉ D’ANGERS

Economic development structures College

  • Jean-François Balducchi –  ATLANPOLE
  • Hélène Le Pocher – BIOTECH SANTÉ BRETAGNE
  • Quentin Renoul – ANGERS TECHNOPOLE
  • Fabien Riolet – POLEPHARMA